Novel Endoscopic Management of a Chronic Gastro-Gastric Fistula Using a Cardiac Septal Defect Occluder
Carregando...
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
HATHORN, Kelly E.
BAPTISTA, Alberto
THOMPSON, Christopher C.
Citação
OBESITY SURGERY, v.30, n.8, p.3253-3254, 2020
Resumo
Purpose Closure of GG fistulas after RYGB is challenging due to epithelialization of the tract. Common endoscopic therapies are less efficacious than surgical revision, which is unfortunately fraught with high morbidity and mortality. Cardiac septal defect occluders (CSDO) have been successfully used for the management of gastrointestinal fistulas, but use has never been reported in management of GG fistulas. Thus, we describe the first off-label use of CSDO for the treatment of a GG fistula. Materials and Methods Endoscopy and fluoroscopic examination determined the appropriate size of CSDO for closure. A guidewire was placed in the remnant stomach followed by placement of the delivery system. Then, under fluoroscopy, we deployed the first flange of the CSDO in the remnant stomach. Then, under fluoroscopy and endoscopic visualization, the second flange is deployed in the gastric pouch. Results A 51-year-old woman, status-post RYGB in 2008, presented with a 6-month history of weight regain and reflux. She had regained weight to 84 kg (BMI = 32 kg/m2) when she was found to have a GG fistula. She underwent successful CSDO placement and, 3 months later, had lost 10 kg with significant improvement in her reflux. Repeat evaluation confirmed successful fistula closure. Conclusion The use of CSDO was technically feasible and appeared to be effective and safe. Future studies should continue to investigate the role of CSDO in management of this challenging condition.
Palavras-chave
Obesity, Bariatric, Fistula, GERD, Endoscopy, Surgery
Referências
- Baptista A, 2019, GASTROINTEST ENDOSC, V89, P671, DOI 10.1016/j.gie.2018.11.034
- de Moura Diogo T H, 2018, Curr Treat Options Gastroenterol, V16, P386, DOI 10.1007/s11938-018-0199-6